pillbase.ru

Oxlumo

Active substance: lumasiran

Lumasiran sodium

Centralised EU authorisationActive

Marketing holder: Alnylam Netherlands B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • OXLUMO
    INJECTION, SOLUTION · LUMASIRAN SODIUM 94.5 mg/.5mL
    71336-1002
    Alnylam Pharmaceuticals, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-c61d-74f3-9168-f960af9b81a4;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005040
Registration status
Active
ATC code
A16AX18
Sources
  • product · EMA · EMEA/H/C/005040 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005040 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005040 · Verified 2026-10-09